26 May 2013
Keywords: Pfizer, Watson, Actavis, Rapamune, Patent dispute, Organ transplantation
Article | 01 February 2013
Global pharma behemoth Pfizer (NYSE: PFE) says that the US District Court for the District of Delaware ruled that its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 February 2013
31 January 2013
24 May 2013
© 2013 thepharmaletter.com